Giorgberidze I, Saksena S, Krol R B, Mathew P
Arrhythmia & Pacemaker Service, Eastern Heart Institute, Passaic, New Jersey, USA.
Am J Cardiol. 1995 Aug 15;76(5):359-65. doi: 10.1016/s0002-9149(99)80101-5.
Radiofrequency catheter ablation of left-sided accessory pathways (APs) with the use of an endocardial technique carries all potential risks of left heart catheterization. We analyzed the determinants of success, efficacy, and safety of radiofrequency catheter ablation from the coronary sinus (CS), as a potential alternative to the endocardial technique in these patients. Thirteen patients (mean age 40 +/- 20 years) with 15 left-sided APs and a history of symptomatic supraventricular tachycardia were included in the study. Nine APs were localized in the left posteroseptal region, and the remaining 6 in the left free wall. Ablation from CS was attempted in 12 patients with 14 APs. In 1 patient ablation within the CS was not deemed safe because of a small venous lumen. All 14 APs were successfully ablated using either CS ablation alone or combined with the endocardial technique. Efficacy of the CS ablation as a primary technique was 56% (5 of 9 APs). In 5 additional APs, ablation in the CS eliminated pathway conduction after failed endocardial attempts. CS ablation either as a primary or a secondary technique eliminated conduction in 10 of 14 APs (71.4%) (group 1). In the remaining 4 APs (group 2), the primary CS attempt was unsuccessful and APs were ablated with a subsequent endocardial approach. Determinants of success for the CS method were local AP to atrial and/or ventricular electrogram amplitude ratios > or = 1 (p < 0.05). The success rate of CS ablation was 83% in the left posteroseptal APs adjoining the branching point of the middle cardiac vein or a CS anomaly.(ABSTRACT TRUNCATED AT 250 WORDS)
采用心内膜技术经导管射频消融左侧旁路(APs)存在左心导管插入术的所有潜在风险。我们分析了经冠状窦(CS)进行射频导管消融的成功、疗效及安全性的决定因素,作为这些患者心内膜技术的一种潜在替代方法。本研究纳入了13例(平均年龄40±20岁)有15条左侧APs且有症状性室上性心动过速病史的患者。9条APs位于左后间隔区域,其余6条位于左游离壁。12例有14条APs的患者尝试经CS进行消融。1例患者因静脉腔较小,认为在CS内消融不安全。所有14条APs均通过单独CS消融或联合心内膜技术成功消融。CS消融作为主要技术的疗效为56%(9条APs中的5条)。另外5条APs中,心内膜消融失败后,CS内消融消除了旁路传导。CS消融作为主要或次要技术在14条APs中的10条(71.4%)消除了传导(第1组)。在其余4条APs(第2组)中,最初的CS尝试未成功,随后采用心内膜方法消融了APs。CS方法成功的决定因素是局部AP与心房和/或心室电图振幅比≥1(p<0.05)。在毗邻心中静脉分支点或CS异常的左后间隔APs中,CS消融的成功率为83%。(摘要截断于250字)